title: [Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].
authors.forename: K
authors.initials: K
authors.lastname: Hajlaoui
authors.forename: F
authors.initials: F
authors.lastname: Zeglaoui
authors.forename: N
authors.initials: N
authors.lastname: Ezzine
authors.forename: S
authors.initials: S
authors.lastname: Kastalli
authors.forename: N
authors.initials: N
authors.lastname: Elfekih
authors.forename: B
authors.initials: B
authors.lastname: Fazaa
authors.forename: M H
authors.initials: MH
authors.lastname: Loueslati
authors.forename: M R
authors.initials: MR
authors.lastname: Kamoun
mesh_terms: D000368:Aged; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000009:adverse effects*
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate